NOTE :

We are currently translating the 2009-2010 "Medical Management of HIV Infection" into a web-ready format. We will post each chapter as it is completed. To make any comments or suggestions click here

Previous         62         Next
dkfhkd

Discussion Thread

PREFERRED

  • Isoniazid (INH 300 mg po + pyridoxine 50 mg / day x 9 mo
  • INH 900 mg po + pyridoxine 100 mg twice weekly with DOT x 9 mo
  • Exposure to drug resistant TB: Consult expert
  • Alternative to INH: Rifampin 300 mg/day or rifabutin (dose adjusted, see pg ____)
  • Note that the Pyrazinamide (PZA) + rifampin regimen is no longer recommended due to reports of 40 cases of severe hepatotoxicity, including 7 deaths with the PZA + rifampin 2-month regimen (MMWR 2002;51:998; MMWR 2002;51:998; Am Rev Respir Crit Care Med 2001;164:1319). None of these patients was known to have HIV infection, and a subsequent analysis found that only 15 of 721 HIV-infected patients who received rifampin/PZA had ALT levels >250 U/L, a rate similar to that observed in INH recipients (12/745). The conclusion was that hepatotoxicity is rare in HIV-infected patients given rifampin/PZA (CID 2004;39:561).

PREGNANCY: INH regimens

MONITORING:Laboratory monitoring includes baseline tests of liver function (bilirubin ALT, AST and alkaline phosphotase) for INH recipients and liver function tests (as above) plus a CBC for rifampin/ rifabutin recipients (MMWR 2000;49 RR-6:1). Patients should be clinically monitored monthly to detect hepatotoxicity or neuropathy, and they should stop treatment and report any symptoms of hepatitis: jaundice, dark urine, nausea, vomiting, abdominal pain, and/or fever >3 days. INH should be discontinued with ALT elevations to >5x ULN without symptoms or ALT to >3x ULN with symptoms. Monitoring of LFTs is recommended for patients with abnormal baseline LFTs and those receiving ART (Am J Respir Crit Care Med 2006;174: 935).

Toxoplasma gondii

INDICATION: Toxoplasma lgG positive plus CD4 <100 cells/mm3

NOTE: Seronegative patients on PCP prophylaxis that does not cover Toxoplasma should have the serologic test repeated if the CD4 count decreases to <100 cells/mm3

RISK: CD4 count <100 cells/mm3 plus positive anti-Toxoplasma lgG conferes a risk of toxoplasmosis encephalitis of 33%per year (JID 1996;173:91; CID 2001;33:1747).

PREFERRED: TMP-SMX 1 DS/day

ALTERNATIVES

  • TMP-SMX 1 SS/day
  • Dapsone 50 mg/day po + pyrimethamine 50 mg/week + leucovorin 25 mg/week

Chapter 6: Disease Prevention

Page 62 of 451 (0 Posts)

Add Thread | View All Threads

 

ImagesThreadsNamePostsDate

No Threads...